Position in INCY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$9,043,331
-$484,318 QoQ
Shares Held
96,083
-0.4% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Swiss Life Asset Management Ltd holds $100,695,940 across 59 Biotechnology names. INCY ranks #3 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
82,574 | $36,872,593 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
30,525 | $23,584,835 | |
| 3 | INCY |
Incyte Corp
This page
|
96,083 | $9,043,331 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,734 | $7,852,868 | |
| 5 | INSM |
INSMED Inc
|
18,506 | $3,026,101 | |
| 6 | MRNA |
Moderna, Inc.
|
25,661 | $1,303,578 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
12,779 | $1,242,757 | |
| 8 | EXEL |
Exelixis, Inc.
|
22,212 | $952,672 |
All Filings in INCY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,043,331 | 96,083 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $9,527,649 | 96,463 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $7,249,558 | 85,480 | Shares | Defined | 2025-12-02 | |
| 2025-06-30 | $2,073,032 | 30,441 | Shares | Sole | 2025-12-02 | |
| 2025-03-31 | $1,511,024 | 24,955 | Shares | Defined | 2025-12-02 | |
| 2024-12-31 | $1,315,921 | 19,052 | Shares | Sole | 2025-12-09 | |
| 2024-09-30 | $1,495,908 | 22,631 | Shares | Sole | 2025-12-09 | |
| 2024-06-30 | $1,556,902 | 25,683 | Shares | Defined | 2025-12-09 | |
| 2024-03-31 | $1,182,127 | 20,750 | Shares | Sole | 2025-12-09 | |
| 2023-12-31 | $8,794,743 | 140,066 | Shares | Sole | 2025-12-09 | |
| 2023-09-30 | $7,449,961 | 128,959 | Shares | Sole | 2025-12-09 | |
| 2023-06-30 | $4,643,226 | 74,590 | Shares | Sole | 2025-12-09 | |
| 2023-03-31 | $4,752,113 | 65,755 | Shares | Defined | 2025-12-09 | |
| 2022-12-31 | $948,016 | 11,803 | Shares | Defined | 2025-12-09 | |
| 2022-09-30 | $548,380 | 8,229 | Shares | Defined | 2025-12-09 | |
| 2022-06-30 | $637,464 | 8,391 | Shares | Defined | 2025-12-09 | |
| 2022-03-31 | $3,152,735 | 39,697 | Shares | Sole | 2025-12-09 | |
| 2021-06-30 | $452,955 | 5,384 | Shares | Defined | 2025-12-29 | |
| 2021-03-31 | $437,557 | 5,384 | Shares | Defined | 2025-12-29 | |
| 2020-12-31 | $761,248 | 8,752 | Shares | Defined | 2025-12-29 | |
| 2020-06-30 | $944,983 | 9,089 | Shares | Defined | 2025-12-29 | |
| No filing history on record for this holder in this stock. | ||||||